Bruker (BRKR) Cash from Operations (2010 - 2026)

Bruker (BRKR) has reported Cash from Operations for 17 consecutive years, with -$77.4 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cash from Operations rose 39.29% year-over-year to -$77.4 million; the trailing twelve-month figure through Jun 2026 stood at $190.4 million (up 14.77% YoY), and the FY2025 full-year result was $134.1 million, down 46.64% from the prior year.
• Cash from Operations declined to -$77.4 million in Q2 2026 per BRKR's latest filing, from $71.2 million in the prior quarter.
• Across five years, Cash from Operations topped out at $229.8 million in Q4 2025 and bottomed at -$127.5 million in Q2 2025.
• Historically, Cash from Operations has averaged $55.8 million across 5 years, with a median of $54.6 million in 2023.
• The widest YoY moves for Cash from Operations: up 198.17% in 2025, down 11690.91% in 2025.
• Over 5 years, Cash from Operations stood at $171.5 million in 2022, then climbed by 19.83% to $205.5 million in 2023, then fell by 7.54% to $190.0 million in 2024, then rose by 20.95% to $229.8 million in 2025, then sank by 133.68% to -$77.4 million in 2026.
• According to Business Quant data, Cash from Operations over the past three periods registered -$77.4 million, $71.2 million, and $229.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.